RxDoctor Payments Data

Yolanda Lawson, PA

Physician Assistant · Jacksonville, FLNPI 1952071912

Payments from drug & device makers

$10,131in general payments, 2019–2025

Across 558 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$1K
  • AstraZeneca$1K
  • AbbVie$959
  • Novo Nordisk$719
  • Lilly USA, LLC$625
  • Corcept Therapeutics$509
  • plus $5K from 44 others

What the payments were for

  • Food & beverage$10,05799%
  • Education$741%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,131 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$36,971
Medicare patients
116
Services billed
803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide125$139,036
Trelegy ElliptaFluticasone/Umeclidin/Vilanter100$67,674
JardianceEmpagliflozin38$54,997
MounjaroTirzepatide44$46,208
FarxigaDapagliflozin Propanediol20$23,598
EliquisApixaban21$23,497
Nurtec OdtRimegepant Sulfate13$15,934
TrulicityDulaglutide17$15,898
LinzessLinaclotide20$12,697
MyrbetriqMirabegron14$10,961
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$9,577
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$9,114
JanuviaSitagliptin Phosphate12$8,970
RestasisCyclosporine12$7,619
Varenicline Tartrate20$5,324

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$719$139,036125 claims
GSKTrelegy Ellipta, Anoro Ellipta$404$76,788118 claims
Lilly USA, LLCMounjaro, Trulicity$625$62,10761 claims
Boehringer IngelheimJardiance$451$54,99738 claims
PfizerEliquis, Nurtec Odt$70$39,43234 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,126$36,41450 claims
AbbVieLinzess, Restasis$959$20,31632 claims
Astellas Pharma US IncMyrbetriq$65$10,96114 claims
MerckJanuvia$198$8,97012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →